VAP1 (AOC3) (712-724) Goat Polyclonal Antibody
CAT#: AP08978PU-N
VAP1 (AOC3) (712-724) goat polyclonal antibody, Aff - Purified
Need it in bulk or conjugated? 
                            Get a free quote
                        
CNY 5511.00
货期*
                        6周
                    规格
                        Specifications
| Product Data | |
| Applications | ELISA, IHC | 
| Recommend Dilution | ELISA: 1/64000. Immunohistochemistry on Paraffin Sections: 3.75 µg/ml.  | 
        
| Reactivity | Human, Mouse, Rat, Hamster | 
| Host | Goat | 
| Clonality | Polyclonal | 
| Immunogen | Synthetic peptide from an internal region of human AOC3 | 
| Specificity | This antibody reacts to Copper Amine Oxidase (AOC3) at aa 712-724. | 
| Formulation | Tris saline buffer, pH 7.3, 0.5% BSA, 0.02% sodium azide State: Aff - Purified State: Liquid purified Ig  | 
        
| Concentration | lot specific | 
| Purification | Immunoaffinity Chromatography | 
| Conjugation | Unconjugated | 
| Storage Condition | Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing.  | 
        
| Gene Name | amine oxidase, copper containing 3 | 
| Database Link | |
| Background | VAP1, upregulated in response to inflammation, is a cell adhesion protein that participates in lymphocyte recirculation, by mediating the binding of lymphocytes to peripheral lymph node vascular endothelial cells, in an L selectin independent fashion. VAP1 also displays a monoamine oxidase activity, catalyzing the deamination of methylamine to produce formaldehyde. Upregulation of VAP1 has been reported in Alzheimer's disease, where increased levels of formaldehyde are responsible for b amyloid cross linkage and plaque formation, significantly contributing to the pathogenesis of this disease. | 
| Synonyms | HPAO | 
| Reference Data | |
Documents
| Product Manuals | 
| FAQs | 
| SDS | 
Resources
| 抗体相关资料 | 
                         Customer
                                Reviews 
                    
                    
                                Loading...
                            
                        